Request that the FDA grant permission to file an abbreviated new animal drug application (ANADA) for a generic soft chewable tablet for Graphiprant that differs from the pioneer product Galliprant (grapiprant tablets), sponsored by Elanco US Inc, under NADA 141-455 | Federal Regulations · Congress.wiki